• Webinar Details

  • Home / Learn / Live CE / Live CE Event Calendar / Webinar Details


It’s On Aisle 6: An Exploration of the Cough & Cold Aisle

Event Type

Live Online

Date

Wednesday, August 24, 2022

Time

10:30 AM - 11:45 AM ET

Location

PharmCon Webinar Studio (freeCE.com)

Credits

1.25 Contact Hour(s)

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$0.00

  • Overview

    The cough and cold aisle can seem overly daunting to patients. Combination products abound and even trade names carry a variety of active ingredients. Too often, the response to inquiries about over the counter medications is simply, “It’s on Aisle 6.” As healthcare providers, however, we have so much more to offer. This session takes a comprehensive look at the items found in the ‘cough and cold’ aisle and identifies the major patient advisement points for these medications. Join us as we go beyond “aisle 6” and explore the ancillary opportunities that await.

    Handouts

    Slide Document:   21140L01_2pp.pdf


    Slide Document:   21140L01_6pp.pdf

    Financial Support By

    PharmCon
  • Nurse

    Differentiate between the various antihistamines available over the counter
    Identify special patient populations that should avoid specific over the counter products
    Recognize when further referral for work up is advised
    Identify over the counter medications that are commonly abused


    Pharmacist

    Differentiate between the various antihistamines available over the counter
    Identify special patient populations that should avoid specific over the counter products
    Recognize when further referral for work up is advised
    Identify over the counter medications that are commonly abused


    Pharmacy Technician

    Differentiate between the various antihistamines available over the counter
    Identify special patient populations that should avoid specific over the counter products
    Recognize when further referral for work up is advised
    Identify over the counter medications that are commonly abused

  • Repeat Presentation

    This presentation was last given on Wednesday, April 6, 2022

    Future Airings

    DateTime 
    Friday, October 14, 20222:00 PMView
    Monday, November 28, 20224:00 PMView
    Thursday, December 15, 20224:00 PMView

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-21-140-L01-N

    Pharmacist 0798-0000-21-140-L01-P

    Pharmacy Technician 0798-0000-21-140-L01-T

    ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

  • Faculty

    Kevin Hope, RPh
    Senior Director of Continuing Education, PharmCon




HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

 

©2015 PharmCon All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.